SE532250C2 - New formulations of IL-33 for the treatment of inflammatory conditions with a strong TH2 component by vaccination - Google Patents

New formulations of IL-33 for the treatment of inflammatory conditions with a strong TH2 component by vaccination

Info

Publication number
SE532250C2
SE532250C2 SE0602549A SE0602549A SE532250C2 SE 532250 C2 SE532250 C2 SE 532250C2 SE 0602549 A SE0602549 A SE 0602549A SE 0602549 A SE0602549 A SE 0602549A SE 532250 C2 SE532250 C2 SE 532250C2
Authority
SE
Sweden
Prior art keywords
vaccination
il
treatment
inflammatory conditions
new formulations
Prior art date
Application number
SE0602549A
Other languages
Swedish (sv)
Other versions
SE0602549L (en
Inventor
Lars Hellman
Original Assignee
Theravac Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravac Pharmaceuticals Ab filed Critical Theravac Pharmaceuticals Ab
Priority to SE0602549A priority Critical patent/SE532250C2/en
Publication of SE0602549L publication Critical patent/SE0602549L/en
Publication of SE532250C2 publication Critical patent/SE532250C2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0008Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
SE0602549A 2006-11-28 2006-11-28 New formulations of IL-33 for the treatment of inflammatory conditions with a strong TH2 component by vaccination SE532250C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE0602549A SE532250C2 (en) 2006-11-28 2006-11-28 New formulations of IL-33 for the treatment of inflammatory conditions with a strong TH2 component by vaccination

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0602549A SE532250C2 (en) 2006-11-28 2006-11-28 New formulations of IL-33 for the treatment of inflammatory conditions with a strong TH2 component by vaccination
PCT/SE2007/001036 WO2008066443A1 (en) 2006-11-28 2007-11-26 Il-33 vaccine for the treatment of inflammatory conditions with a strong th2 component

Publications (2)

Publication Number Publication Date
SE0602549L SE0602549L (en) 2008-05-29
SE532250C2 true SE532250C2 (en) 2009-11-24

Family

ID=39468147

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0602549A SE532250C2 (en) 2006-11-28 2006-11-28 New formulations of IL-33 for the treatment of inflammatory conditions with a strong TH2 component by vaccination

Country Status (2)

Country Link
SE (1) SE532250C2 (en)
WO (1) WO2008066443A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054012A1 (en) 2013-10-07 2015-04-16 The Trustees Of The University Of Pennsylvania Vaccines with interleukin-33 as an adjuvant
KR20170080604A (en) 2014-11-10 2017-07-10 제넨테크, 인크. Anti-interleukin-33 antibodies and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846486B1 (en) * 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
NZ549040A (en) * 2004-02-17 2009-07-31 Schering Corp Use for interleukin-33 (IL33) and the IL-33 receptor complex

Also Published As

Publication number Publication date
WO2008066443A1 (en) 2008-06-05
SE0602549L (en) 2008-05-29

Similar Documents

Publication Publication Date Title
ITPI20070108A1 (en) Method perfected for the automatic realization of conglomerate structures
ITFI20080201A1 (en) Robot System endoluminal
AT509020T (en) 3-cyano-4- (4-tetrahydropyranphenyl) pyridin-2-one derivatives
SE1250881A1 (en) Components for medical circles
SE530362C2 (en) The drive with flying splicing
SE1051181A1 (en) Dental bridges and superstructures, as well as methods for making these
SMT201500142B (en) Method for the purification of proteins
SE532783C2 (en) The granulator
FI20060537A0 (en) The drive current measuring
SE539153C2 (en) The drive coupling for DTH
SE0950407A1 (en) Handling the transaction
SE1100883A1 (en) Method and composition for the control of ectoparasites
SE530059C2 (en) Process for the preparation of a bis-phthalonitrile monomer
SE532008C2 (en) The refining plate segment with triangular inlet features
IT1400757B1 (en) dust Apparatus for self-propelled floors
SE530609C2 (en) Multicoupling comprising central drive means
SE534491C2 (en) Device for removal of selected parts of the assembled pallets
ITFI20060195A1 (en) Support system perfected multidirectional antiseismic
ITBO20090142A1 (en) Device for the dissolution of solid substances
SE532952C2 (en) Set for setting the drive voltage of the LCD unit
ITMI20101375A1 (en) dust Apparatus for self-propelled floors
SE530029C2 (en) Position the powertrain
ITMI20090663A1 (en) Method for the purification of paliperidone
SE532251C2 (en) New formulations of TSLP for the treatment of TH2 mediated inflammatory diseases by vaccination
SE0901125A1 (en) Process for compensation of turbulence at the pick of movie sequences